Intravenous Omeprazole Dosing in Pediatrics
For pediatric patients requiring IV omeprazole, use 1 mg/kg every 12 hours (twice daily), as this dose achieves effective acid suppression comparable to adult therapeutic levels and has been demonstrated to be hemodynamically safe in critically ill children.
Weight-Based Dosing Algorithm
The evidence supports the following IV dosing approach:
- Standard IV dose: 1 mg/kg every 12 hours 1
- Alternative lower dose: 0.5 mg/kg every 12 hours may be considered, though less effective 2, 1
- Administration: Infuse over 20 minutes via continuous infusion pump 2
Rationale for 1 mg/kg Dosing
Population pharmacokinetic modeling in critically ill children demonstrated that 1 mg/kg IV achieves similar drug exposure (area under the curve) to the standard 20 mg adult dose, making it the most appropriate weight-based equivalent 1. In contrast, lower doses of 0.5 mg/kg showed inadequate acid suppression.
A key pharmacokinetic study in infants younger than 30 months found that 40 mg/1.73 m² (approximately 1-1.3 mg/kg) maintained gastric pH >4 for 90.6% of monitored time, while 20 mg/1.73 m² (approximately 0.5-0.7 mg/kg) achieved this only 44.8% of the time 3. This provides strong evidence that higher dosing is necessary for therapeutic effect.
Safety Profile
Hemodynamic safety has been specifically established for both 0.5 mg/kg and 1 mg/kg doses in critically ill children 2. A prospective study of 37 critically ill children (ages 1 month to 14 years) showed:
- No significant changes in heart rate, blood pressure, or central venous pressure
- No ECG abnormalities
- No requirement for inotropic therapy modification
- No differences in safety between the two dose levels
Oral to IV Conversion Context
While the FDA-approved oral dosing for pediatric GERD is weight-tiered (10 mg for <20 kg, 20 mg for ≥20 kg once daily) 4, these oral doses should not be directly applied to IV administration. The IV route requires different dosing due to:
- First-pass metabolism bypass
- Different pharmacokinetic profiles
- Rapid elimination in pediatric patients 3
Clinical Caveats
Important considerations:
- Age range: Safety and efficacy data exist for children 1 month to 14 years 2, 3
- Duration: Administer as 20-minute infusion, not bolus 2
- Monitoring: While hemodynamically safe, standard monitoring of vital signs is appropriate
- Transition to oral: Once able to take oral medications, transition to FDA-approved oral dosing (0.7-3.3 mg/kg daily for children 2-16 years) 5, 4
Common pitfall to avoid: Do not use adult fixed dosing (20-40 mg) in children, as this fails to account for the higher weight-adjusted clearance in pediatric patients. Allometric size models predict that body weight significantly affects all pharmacokinetic parameters 1.
Maximum Dosing
While no absolute maximum is specified in pediatric IV literature, the oral guideline range of 0.7-3.3 mg/kg daily 5 suggests that 1 mg/kg every 12 hours (2 mg/kg/day total) falls within established safe limits for pediatric omeprazole exposure.